Table 1. Demographics and baseline characteristics of newly referred patients with uveitis requiring tertiary care for at least 1 year.
| Total no. of patients | 133 |
| Total no. of eyes | 219 |
| Age at onset of uveitis (years) | |
| Mean (±SD) | 42.6 (±18.1) |
| Median | 43 |
| Range | 5–83 |
| Age at referral (years) | |
| Mean (±SD) | 45.1 (±18.3) |
| Median | 47 |
| Range | 7–85 |
| Male-to-female ratio | 1 : 2.4 |
| Unilateral-to-bilateral ratio | 1 : 1.8 |
| Race | N (% of total) |
| Caucasian | 88/133 (66%) |
| Black | 21/133 (16%) |
| Asian | 12/133 (9%) |
| Mixed race | 2/133 (2%) |
| Other racesa | 7/133 (5%) |
| Unknown | 3/133 (2%) |
| Anatomical localization | N (% of total) |
| Anterior uveitis | 35/133 (26%) |
| Intermediate uveitis | 13/133 (10%) |
| Posterior uveitis | 27/133 (20%) |
| Panuveitis | 58/133 (44%) |
| Etiology | N (% of total) |
| Associated systemic disease | 60/133 (45%) |
| Sarcoidosisb | 27/60 (45%) |
| HLA-B27-associated uveitisc | 11/60 (18%) |
| Multiple Sclerosis | 5/60 (8%) |
| Otherd | 17/60 (28%) |
| Established ocular entity | 17/133 (13%) |
| Birdshot chorioretinopathy | 4/17 (24%) |
| Hypertensive anterior uveitis | 4/17 (24%) |
| Othere | 9/17 (53%) |
| Infectious | 14/133 (11%) |
| Toxoplasmosis | 6/14 (43%) |
| HSV and VZV-associated uveitis | 5/14 (36%) |
| Other infectious causesf | 3/14 (21%) |
| Idiopathic | 42/133 (32%) |
| Latent tuberculosis-associated uveitis | 7/42 (17%) |
Abbreviation: HLA-B27-associated uveitis, human leukocyte antigen-B27-associated uveitis.
Includes six with North-African decent and one Hispanic patient.
Includes 19 definitive and 8 presumed sarcoidosis.
Including patients with and without spondyloarthropathy.
Includes juvenile idiopathic arthritis (n=3), Vogt–Koyanagi–Harada syndrome (n=3), Behcet's disease (n=3), inflammatory bowel disease (n=2), systemic lupus erythematodes (n=1), granulomatous polyangiitis (n=1), scleroderma-associated uveitis (n=1), periarteritis nodosa (n=1), masquerade syndrome (n=1), and systemic sclerosis (CREST syndrome; n=1).
Includes Fuchs hetereochromic uveitis (n=2), pars planitis (n=2), white dot syndrome (n=2), phacogenic uveitis (n=1), serpiginous uveitis (n=1), and presumed ocular histoplasmosis syndrome (n=1).
Includes two patients with rubella virus-associated uveitis and one patient with cytomegalovirus-associated uveitis.